Nuveen Asset Management’s Pulse Biosciences PLSE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $990K | Sell |
56,846
-58,276
| -51% | -$1.01M | ﹤0.01% | 2717 |
|
|
2024
Q3 | $2.02M | Buy |
115,122
+54,786
| +91% | +$961K | ﹤0.01% | 2405 |
|
|
2024
Q2 | $675K | Buy |
60,336
+33,964
| +129% | +$380K | ﹤0.01% | 2891 |
|
|
2024
Q1 | $230K | Hold |
26,372
| – | – | ﹤0.01% | 3157 |
|
|
2023
Q4 | $323K | Buy |
26,372
+3,607
| +16% | +$44.2K | ﹤0.01% | 3132 |
|
|
2023
Q3 | $91.7K | Sell |
22,765
-3,788
| -14% | -$15.3K | ﹤0.01% | 3131 |
|
|
2023
Q2 | $191K | Buy |
+26,553
| New | +$191K | ﹤0.01% | 3087 |
|
|
2022
Q2 | – | Sell |
-36,567
| Closed | -$186K | – | 3363 |
|
|
2022
Q1 | $186K | Hold |
36,567
| – | – | ﹤0.01% | 3202 |
|
|
2021
Q4 | $598K | Hold |
36,567
| – | – | ﹤0.01% | 3023 |
|
|
2021
Q3 | $836K | Sell |
36,567
-4,563
| -11% | -$104K | ﹤0.01% | 3053 |
|
|
2021
Q2 | $675K | Sell |
41,130
-11,844
| -22% | -$194K | ﹤0.01% | 3123 |
|
|
2021
Q1 | $1.25M | Sell |
52,974
-8,737
| -14% | -$207K | ﹤0.01% | 2816 |
|
|
2020
Q4 | $1.47M | Sell |
61,711
-5,620
| -8% | -$134K | ﹤0.01% | 2656 |
|
|
2020
Q3 | $793K | Buy |
67,331
+331
| +0.5% | +$3.9K | ﹤0.01% | 2786 |
|
|
2020
Q2 | $701K | Buy |
67,000
+26,605
| +66% | +$278K | ﹤0.01% | 2772 |
|
|
2020
Q1 | $289K | Sell |
40,395
-215
| -0.5% | -$1.54K | ﹤0.01% | 2927 |
|
|
2019
Q4 | $544K | Hold |
40,610
| – | – | ﹤0.01% | 2890 |
|
|
2019
Q3 | $627K | Sell |
40,610
-2,164
| -5% | -$33.4K | ﹤0.01% | 2877 |
|
|
2019
Q2 | $564K | Buy |
+42,774
| New | +$564K | ﹤0.01% | 2957 |
|